These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24518843)

  • 1. [Reported adverse events following influenza vaccination].
    van Balveren-Slingerland L; Rümke HC; Kant AC
    Ned Tijdschr Geneeskd; 2014; 158():A6841. PubMed ID: 24518843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017.
    Gattás VL; Braga PE; Koike ME; Lucchesi MBB; Oliveira MMM; Piorelli RO; Queiroz V; Precioso AR
    Rev Inst Med Trop Sao Paulo; 2018 Dec; 61():e4. PubMed ID: 30570077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Woo EJ; Moro PL; Cano M; Jankosky C
    Vaccine; 2017 Oct; 35(42):5618-5621. PubMed ID: 28886946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].
    Labadie J; van Grootheest AC
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2738-42. PubMed ID: 18225798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
    Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
    Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.
    van Puijenbroek EP; Broos N; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1097-108. PubMed ID: 21077700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
    Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands.
    Broos N; van Puijenbroek EP; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1109-15. PubMed ID: 21077701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective study.
    Ankrah DN; Mantel-Teeuwisse AK; De Bruin ML; Amoo PK; Ofei-Palm CN; Agyepong I; Leufkens HG
    Drug Saf; 2013 Apr; 36(4):259-66. PubMed ID: 23508545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.
    Carnovale C; Raschi E; Leonardi L; Moretti U; De Ponti F; Gentili M; Pozzi M; Clementi E; Poluzzi E; Radice S
    Expert Rev Vaccines; 2018 Apr; 17(4):363-381. PubMed ID: 29452497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-vaccination healthcare attendance rate as a proxy measure for syndromic surveillance of adverse events following immunisation.
    Mesfin YM; Cheng AC; Enticott J; Lawrie J; Buttery J
    Aust N Z J Public Health; 2021 Apr; 45(2):101-107. PubMed ID: 33617131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on surveillance data of adverse events following immunization of seasonal influenza vaccine in China during 2015-2018 influenza season].
    Wu WD; Li KL; Xu DS; Ye JK; Xiao QY; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):987-992. PubMed ID: 31607043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.